Início/Ações/VERU

VERU

USD

Veru Inc. Common Stock

$0.653-0.007 (-1.061%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$0.660

Máximo

$0.685

Mínimo

$0.612

Volume

1.69M

Fundamentos da empresa

Capitalização de mercado

95.7M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

2.33M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.45Atual $0.653Máximo $1.42

Notícias relacionadas

28/05/2025 · 10:30

GlobeNewswire

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and

Ver mais

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

8/05/2025 · 10:30

GlobeNewswire

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress

--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of

Ver mais